Bafna Pharmaceuticals Limited (BAFNAPH.NS)
- Previous Close
76.92 - Open
80.69 - Bid --
- Ask --
- Day's Range
75.00 - 80.70 - 52 Week Range
69.00 - 113.00 - Volume
17,982 - Avg. Volume
2,431 - Market Cap (intraday)
1.902B - Beta (5Y Monthly) 0.47
- PE Ratio (TTM)
44.18 - EPS (TTM)
1.82 - Earnings Date May 27, 2025 - May 31, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Sep 19, 2013
- 1y Target Est
--
Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, and internationally. The company was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited operates as a subsidiary of SRJR Lifesciences LLP.
www.bafnapharma.com363
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: BAFNAPH.NS
View MorePerformance Overview: BAFNAPH.NS
Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BAFNAPH.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BAFNAPH.NS
View MoreValuation Measures
Market Cap
1.89B
Enterprise Value
2.06B
Trailing P/E
44.18
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.28
Price/Book (mrq)
2.30
Enterprise Value/Revenue
1.39
Enterprise Value/EBITDA
16.52
Financial Highlights
Profitability and Income Statement
Profit Margin
2.90%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
1.48B
Net Income Avi to Common (ttm)
42.97M
Diluted EPS (ttm)
1.82
Balance Sheet and Cash Flow
Total Cash (mrq)
13.15M
Total Debt/Equity (mrq)
22.75%
Levered Free Cash Flow (ttm)
--